JDRF funding opportunities

We offer a wide range of funding schemes for qualified researchers in the field of type 1 diabetes and its associated complications.

The following JDRF funding opportunities are administered by our central office in New York. Applications must be submitted via RMS360, the JDRF Grant Management System. This page provides applicants with guidelines for application submission.

Please follow the links below to find out more about these opportunities.

Targeted schemes

Alpha Cell Function
-Not currently opened

Artificial Pancreas
 -Not currently opened

Behavioural Health and Psychology
Telehealth in Type 1 Diabetes behavioral Health and Psychology
Earliest start date: 01/05/2020

Beta Cell Regeneration and Survival
Discovery and Development of strategies for targeted drug delivery to human islets for T1D
Earliest Award notification: 31/07/2020
Earliest start date: 01/09/2020

Beta Cell Replacement Therapies
3D Bioprinting and Biofabrication of Rationally designed engineered tissue constructs as therapeutic products for treatment of Type 1 Diabetes
Earliest Award notification: 30/04/2020
Earliest start date: 30/06/2020

Complications
Novel Therapeutic Strategies to Prevent or Delay Progression of Early Stage Diabetic Nephropathy
Earliest Award notification: 31/07/2020
Earliest start date: 30/09/2020

– Novel Therapeutic Strategies to Prevent or Delay Progression or Early Stage Diabetic Retinopathy
Earliest Award notification: 31/05/2020
Earliest start date: 31/07/2020

Immunotherapies
– Therapeutic Development and Clinical Testing of Immune Therapies for Type 1 Diabetes
Earliest Award notification: 31/03/2020
Earliest start date: 01/05/2020

– Decoding Immune Mediated Diseases – Novel Approaches for Therapeutic Insights
Earliest Award notification: 31/05/2020
Earliest start date: 01/08/2020

Metabolic Control
Repositioning Drugs to Improve Metabolic Control in Established Type 1 Diabetes
Earliest Award notification: 31/03/2020
Earliest start date: 01/07/2020

Safe and Effective Use of SGLT Inhibitors for Type 1 Diabetes
Earliest Award notification: 31/05/2020
Earliest start date: 31/08/2020

Prevention
The Role of the Microbiome in Type 1 Diabetes: Pathogenesis and Therapeutic Utility
Earliest Award notification: 30/04/2020
Earliest start date: 01/07/2020

TrialNet
– Not currently opened

Training funding schemes

These funding sources are typically available annually

Postdoctoral Fellowships
– Open to those at a relatively early stage of their career.
– PhD, MD, DMD, DVM, or equivalent received no more than five years before the application is submitted. Must not be simultaneously serving an internship or residency.
– Up to  $57,984 to $69,060 per year, for up to 3 years.
– The application deadline was 2 July 2019.

Advanced Postdoctoral Fellowships
– Open to those who have completed some postdoctoral training, show extraordinary promise and are preparing for a transition to an independent research position.
– PhD, MD, DMD, DVM, or equivalent received no more than six years before the application is submitted. Must not be simultaneously serving an internship or residency.
– Up to $95,000 per year, for up to 3 years.
– The application deadline was 2 July 2019.

Career Development Awards
– Open to individuals at an early stage of their independent academic career.
– PhD, MD, DMD, DVM, or equivalent and in an academic faculty-level position since less than 3 years before the submission date.
– Up to $150,000 per year, for up to 5 years.
– The application deadline was 2 July 2019.

Early Career Patient-Orientated Diabetes Research Awards
– Open to clinical researchers at a relatively early stage of their independent career.
– MD or MR-PhD and in their first faculty-level appointment less than 5 years before the submission date.
– Up to $150,000 per year, for up to 5 years.
– The application deadline was 2 July 2019.

Ongoing funding schemes

Project Concepts for Strategic Research Agreements
– Funding for single or multiple investigators to address critical gaps and challenges and potential breakthroughs in Type 1 diabetes research.
– PhD, MD, DMD, DVM, or equivalent and in a faculty position or equivalent.
– Project concept application deadlines 1 August 2019, 4 November 2019 and 3 February 2020.
– Successful Project Concept applicants will be contacted by JDRF personnel on 19 March 2020 and invited to submit Strategic Research Agreement proposal.

Innovative Grants
– Funding for highly innovative research proposals with significant potential to accelerate JDRF’s mission.
– PhD, MD, DMD, DVM, or equivalent and in a faculty position or equivalent.
– Up to $110,000 per year, for up to 1 year.

Other funding schemes

Industry Discovery & Development Partnerships
– Aimed to promote for-profit interest in JDRF’s mission to find a cure for type 1 diabetes and its complications.
– Biotechnology/ pharmaceutical companies or other for-profit entities, either publicly or privately held.
– JDRF also encourages Partnership applications from companies proposing collaboration with academic researchers.
– Discovery Partnerships: 2 year contract – Up to $250K/yr/2
– Contact the appropriate Therapeutic Area Program Director.

Conference Grants
– Supports scientific meetings, conferences, and workshops relevant to JDRF mission.
– Does not provide individual support to an applicant for conference attendance.
– Applications are accepted for consideration throughout the year. They should be submitted to the appropriate Scientific Program Staff 3-6 months prior to the meeting date.